AIM
BIO icon

Anchor Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Anchor Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5
Closed -$2.48K – 983
2022
Q2 		$2.48K Hold
5
– – ﹤0.01% 878
2022
Q1 		$2.82K Hold
5
– – ﹤0.01% 886
2021
Q4 		$3.78K Buy
+5
New +$3.74K ﹤0.01% 897

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Anchor Investment Management's BIO Position: Q3 2022 in Review

Anchor Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 5 shares — an estimated $2.48K sold.

Anchor Investment Management first reported a position in BIO in Q4 2021 and held it in 3 quarters. The position peaked at $3.78K in Q4 2021. 485 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • Anchor Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • Anchor Investment Management sold 5 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $2.48K.
  • Anchor Investment Management first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 3 quarters.
  • Anchor Investment Management's Bio-Rad Laboratories Class A position peaked at $3.78K in Q4 2021.
  • 485 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Anchor Investment Management's 13F filing for Q3 2022, filed 2 Jan 2024.